Vanda Pharmaceuticals (VNDA) Tops Q2 EPS by 31c
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $5.22 +3.78%
Financial Fact:
Income (loss) from operations: -653K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income (loss) from operations: -653K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q2 EPS of $0.03, $0.31 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $42.06 million versus the consensus estimate of $40.31 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Movano (MOVE) Misses Q2 EPS by 195c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
